Abiopharma

ABN AMRO is a holding company. Through its subsidiaries, Co. is engaged as a universal banking group that offers a range of commercial and investment banking products and services on a global basis. Co. has over 3,500 branches in almost 60 countries and territories. Co. implements its strategy through Strategic Business Units: Consumer & Commercial Clients (C&CC), Wholesale Clients (WCS), Private Clients (PC), Asset Management (AM), Private Equity (PE), and Group Functions/Group Shared Services (GF / GSS). As of Dec. 31, 2005, Co. had total consolidated assets of Euro880.804 billion.

Additional info from OTC:
ABN AMRO serves Retail, Private and Corporate Banking clients with a focus on the Netherlands and selective operations internationally. Clients are offered a comprehensive and full range of products and services through omni-channel distribution, including advanced mobile applications and internet banking.

ABN AMRO offers in-depth financial expertise and extensive knowledge of numerous industry sectors. Internationally, the Groups operations are based on specific expertise and established market positions.

Additional info from OTC:
ABN AMRO is a holding company. Through its subsidiaries, Co. is engaged as a universal banking group that offers a range of commercial and investment banking products and services on a global basis. Co. has over 3,500 branches in almost 60 countries and territories. Co. implements its strategy through Strategic Business Units: Consumer & Commercial Clients (C&CC), Wholesale Clients (WCS), Private Clients (PC), Asset Management (AM), Private Equity (PE), and Group Functions/Group Shared Services (GF / GSS). As of Dec. 31, 2005, Co. had total consolidated assets of Euro880.804 billion.